Clinical Trial

First-in-human Study of Orally Administered KT-579 in Healthy Adult Participants

Name: First-in-human Study of Orally Administered KT-579 in Healthy Adult Participants — clinical trial record (NCT07412288)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a first-in-human study to evaluate safety and tolerability, pharmacokinetics, and pharmacodynamics of single and multiple dose levels of KT-579 in healthy male and female adult participants.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-02-09.

Trial Details

NCT Number	NCT07412288
Lead Sponsor	Kymera Therapeutics, Inc.
Conditions	Healthy Participants
Enrollment	96 participants
Start Date	2026-02-23
Primary Completion	2026-12 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2026-02-27